HTT and Huntington disease: An early study reported that in the R6/2 transgenic HD mouse model, exon1 of the mutant human HTT gene was expressed and driven by the human huntingtin promoter [206].Treatment with Nec-1 can ameliorated symptoms and delayed disease progression in mice, and determine the role of RIPK1 in disease progression [207].